UOC
OFIX icon

UBS O'Connor’s Orthofix Medical OFIX Stock Holding History

UBS O'Connor’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-67,518
Closed -$753K – 408
2025
Q2 		$753K Sell
67,518
-21,541
-24% -$267K 0.02% 249
2025
Q1 		$1.45M Sell
89,059
-8,402
-9% -$147K 0.03% 150
2024
Q4 		$1.7M Buy
97,461
+12,578
+15% +$219K 0.04% 174
2024
Q3 		$1.33M Buy
84,883
+7,885
+10% +$126K 0.03% 245
2024
Q2 		$1.02M Sell
76,998
-7,251
-9% -$99.4K 0.03% 293
2024
Q1 		$1.22M Buy
84,249
+4,000
+5% +$55.3K 0.04% 256
2023
Q4 		$1.08M Sell
80,249
-27,783
-26% -$326K 0.03% 257
2023
Q3 		$1.39M Buy
108,032
+40,000
+59% +$720K 0.02% 293
2023
Q2 		$1.23M Buy
68,032
+3,352
+5% +$62.6K 0.03% 363
2023
Q1 		$1.08M Buy
+64,680
New +$1.27M 0.03% 396

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS O'Connor's OFIX Position: Q3 2025 in Review

UBS O'Connor sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 67,518 shares — an estimated $753K sold.

UBS O'Connor first reported a position in OFIX in Q1 2023 and held it in 10 quarters. The position peaked at $1.7M in Q4 2024. 145 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

  • UBS O'Connor reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 67,518 Orthofix Medical shares in Q3 2025, an estimated $753K.
  • UBS O'Connor first reported a position in Orthofix Medical in Q1 2023 and held it in 10 quarters.
  • UBS O'Connor's Orthofix Medical position peaked at $1.7M in Q4 2024.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.